The Colton Consortium for Autoimmunity

Colton Consortium Virtual Speaker Series ft. Yaakov Levine, PhD

Are you part of the #autoimmunity or #immunology research community? Join us Feb. 17 at 11 AM ET for a seminar with Yaakov Levine, PhD (SetPoint Medical), a leader in bioelectronic medicine whose work helped advance FDA-approved vagus nerve–based therapy for rheumatoid arthritis. bit.ly/LevineFeb17

Colton Consortium Virtual Speaker Series. Multiome Profiling in Human Type 1 Diabetes featuring Golnaz Vahedi, PhD (University of Pennsylvania). Jan. 20, 2026 (11am ET). Registration required [QR CODE].

Join the Colton Consortium Virtual Speaker Series on Jan. 20 (11am ET) ft. Golnaz Vahedi, PhD (@upenn.edu). Her recent work identifies a hidden subset of immune “attack” cells that emerge early in Type 1 diabetes—offering clues for blood-based detection and earlier intervention. bit.ly/VahediJan20

YouTube video by Autoimmune Association Autoimmune Voices Threads of Hope: Episode 4 – The Nobel Prize

In the latest Autoimmune Association podcast, Dr. Nina Luning Prak (@upenn.edu, @penncoltoncenter.bsky.social) speaks with 2025 Nobel Laureates in Medicine, Dr. Mary Brunkow and Dr. Fred Ramsdell about the landmark discovery of FOXP3 and regulatory T cells (Tregs). youtu.be/FsFbsnGAqm8?...

Colton Consortium Virtual Speaker Series. Immunoception: Brain Representation and Control of Peripheral Immune States. Featuring Asya Rolls, PhD. Dec. 16, 2025 (11:00 am ET). QR code. Registration required.

The Colton Consortium invites the #autoimmunity and #immunology communities to a virtual seminar with Asya Rolls, PhD (Tel Aviv University). Her research uncovers how the brain regulates #immunity—showing how mental states shape disease trajectories. https://bit.ly/RollsDec16

Using Existing Drugs in New Ways to Treat & Cure Diseases of Brain & Body | Dr. David Fajgenbaum Dr. David Fajgenbaum shares how he survived Castleman's disease using repurposed drugs and reveals how approved medications can treat diseases beyond their original use.

Colton Consortium-affiliated researcher David Fajgenbaum, MD, MBA, MSc joins the Huberman Lab podcast to explore how repurposed, FDA-approved drugs can open new possibilities for #autoimmunity and rare diseases—an approach shaped by his own patient experience.

www.hubermanlab.com/episode/davi...

Colton Consortium Virtual Speaker Series. David Hafler, MD, FANA. “The Gut–Brain Axis in Homeostasis and Disease." Tues, Nov 18, 2025 (11:00 a.m. ET). Virtual. Registration required.

Join us Nov. 18 for the Colton Consortium Virtual Speaker Series! Hear from David Hafler, MD, FANA (@yaleschoolofmed.bsky.social) a leader in #neuroimmunology, on the gut–brain axis in homeostasis and disease. Registration required: bit.ly/HaflerNov18

Dr. Wherry, Director of the Penn Colton Center for Autoimmunity and the Colton Consortium, spoke with The Philadelphia Inquirer about the future of #immunology + #autoimmunity research at Penn—including a new $367M facility—and beyond: “This is the most exciting time in my lifetime for immunology."

The #ColtonConsortium was proud to serve as lead sponsor of the 2025 FASEB #Autoimmunity Conference in Niagara Falls this summer—an influential gathering that advances autoimmune research and fosters collaboration among scientists and clinicians worldwide. Read the recap: https://bit.ly/46Yk1hZ

Colton Consortium Virtual Speaker Series. Dissection of Autoimmunity Through Outliers. Mark Anderson, MD, PhD. Sept. 16, 2025 (11:00 AM ET). Registration required: [QR code]

Are you part of the #immunology and #autoimmunity research communities? Join us next week (9/16, 11AM ET) for "Dissection of Autoimmunity Through Outliers" led by Mark Anderson, MD, PhD (UCSF + @ucsfdc.bsky.social)! Registration for this free virtual event is required: bit.ly/AndersonSept16

Photo of the "overbuild" at 3600 Civic Center Blvd (Philadelphia, PA) at Penn Medicine.

Penn Medicine's new #ImmuneHealth research hub will house the @penncoltoncenter.bsky.social, and many other labs and teams engaged in #immunology work, driving bold, cross-disciplinary collaboration to accelerate discoveries in #AutoimmuneDisease research.

www.pennmedicine.org/news/usherin...

A smiling symposium attendee holds a microphone during an audience Q&A session.

The 2025 Colton Consortium Symposium brought together leaders, researchers, and partners from Penn, NYU, Yale, and Tel Aviv University to share their scientific breakthroughs and plan the next advances in autoimmune disease research.

🔎 Check out our recap: www.coltonconsortium.org/blog/inside-...

YouTube video by Yale Innovation Summit Colton Center for Autoimmunity Showcase | Yale Innovation Summit 2025

The Colton Center for Autoimmunity at Yale led a standout session at the 2025 Yale Innovation Summit, spotlighting top researchers from across the #ColtonConsortium. ▶️ Discover how we’re advancing #autoimmune research and accelerating translational breakthroughs:

Dr. David Fagjenbaum, Associate Professor of Medicine at the University of Pennsylvania and a co-PI of a new Colton Center of Excellence, speaks into a microphone while seated during a Q&A session at the Penn Colton Center for Autoimmunity Symposium in April 2025.

Building on the power of the #ColtonConsortium, the Colton Center for Autoimmunity at the University of Pennsylvania @upenn.edu launched two new Centers of Excellence earlier this year to drive groundbreaking advancements in autoimmune diagnostics and therapeutics: bit.ly/4kRTJCT #autoimmunity